comparemela.com

Latest Breaking News On - Dechra pharmaceuticals - Page 13 : comparemela.com

Form 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

FORM 8.5 PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1.        KEY.

United-states
American
Panel-market-surveillance-unit
Dechra-pharmaceuticals
Regulatory-information-service
Investec-bank
Takeover-code
Regulatory-information
Market-surveillance-unit
Markets

Form 8.3 - Dechra Pharmaceuticals PLC

Form 8.3 - Dechra Pharmaceuticals PLC
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

United-states
American
Joe-brady
Dechra-pharmaceuticals
Rathbones-group-plc
Panel-market-surveillance-unit
Compliance-department
Regulatory-information-service
Takeover-code
Supplemental-form
Open-positions
Regulatory-information

Investegate | Company Announcement

Form 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

FORM 8.5 PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1.        KEY.

United-states
American
Jacq-lovis
Regulatory-information-service
Panel-market-surveillance-unit
Investec-bank
Dechra-pharmaceuticals
Takeover-code
Regulatory-information
Market-surveillance-unit
Markets

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
American
Panel-market-surveillance-unit
Vanguard-group-inc
Dechra-pharmaceuticals
Regulatory-information-service
News-service
Vanguard-group
Takeover-code
Supplemental-form
Open-positions
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.